1 19 M Jimenez, T Ramos, MC CapitBn, and A Gil. 'La Paz' Hospital, Departments of Internal Medicine and Clinical Biochemistry, Universidad Autbnoma, Madrid, Spain. Most patients with primary gout show normal uric acid (UA) production rates and a relative underexcretion of UA. To examine if the renal dysfunction for UA excretion in primary gout also affects the excretion of UA precursors, we compared the plasma concentrations and 24 hour urinary excretion of Hx and X in 10 normal suojects, 15 patients with primary gout and UA underexcretioli and 10 patients with diverse enzyme deficiencies known to overproduce UA. All subjects showed a creatinine clearance above 80 ml/min/1.73 m2. Results (mean+SEM) Adverse reactions to allopurinol frequently involve the skin, liver, kidneys, gastrointestinal system and bone marrow. Pharmacologic studies have suggested that the serum concentration of oxipurinol appear to correlate with the development of lifethreaten~i~g allopurinol toxicity. A male patient (89-years-old) with osy.ttptomatic hyperuricemia (8.1 mg/dl) was treated with allopurinol (300 mg/24 h). No concommitant medications were administered. Six weeks later he presented fever (3gUC), eosinophilia (1.92x109/~), exfoliative dermatitis, hepatocellular injury and renal failure (serum creatinine, 4.6 mg/dl). A plasma sample drawn 8 hours after the patient's last dose of allopurinol showed an oxipurinol concentration by HPLC of 50 pM. This drug was discontinued and prednisone was instituted. His symptoms and epid~rmal necrolysis cleared and liver and renal abnormalities subsltlcd over 2 weeks (serum creatinine, 2.0 mg/dl). Plasma oxipi,rinol levels in 4 patients with uric acid overproduction (3 with HPRT deficiency and 1 with PRPPs overactivity) who were receiving allopurinol (5-10 mg/Kg/24 h) ranged from 48 to 175 pM. No adverse reactions were documented in these patients. This case illustrates that serious hypersensitivity reactions to allopurinol may occur despite plasma oxipurinol concentrations within what it is considered a normal therapeutic level (el00 pM). Primary gout is commonly associated with other metabolic disorders such as obesity, arterial hypertension, hyperlipidemia and diabetes mellitus that usually require a dietary regimen. However, long-term compliance to dietary restrictions may be rejected by subjects with a chronic disease and a peculiar tendency for purine-rich food. Among 175 patients with primary gout, 133 (76%) had associated metabolic disorders: 75 were obese (43%). 63 had arterial hypertension (36%). 67 showed hypercholesterolemia or hypertriglyceridemia (38%) and 10 had diabetes mellitus (6%). Besides gout, 42 patients (24%) had no other metabolic derangements requiring dietary intervention. In these patients a purine-restricted diet ( c 7 5 mg/24 h of purines) for 5 days diminished the serum urate concentration from a base-line value of (mean+SEM) 8.9+0.2 to 7.2t0.2 mg/dl (Pc0.001) and uric acid excretion from 795~53 to 478~29 mg/24 h (P c 0.001). The administration of allopurinol (300 mg/24 h) for 5 days, while patients were on a self-selected diet, reduced serum urate to 5.45.1 mg/dl (Pc0.001) and uric acid excretion to 374~22 mg/24h (P<0.001). These data indicate that allopurinol normalises uric acid metabolism in patients with primary gout who had no associated metabolic disorders, despite the intake of a selfselected diet. Morphologic abnormalities in red blood cells depend on dlverse factors which may include the intracellular centent of oxygen. Hypoxemia increases adenine nucleotide turnover and may influence erythrocyte morphology. To test this hypothesis in 7 patients with cliilically stable COPD we measured red cell ATP (iATP) levels by HPLC and observed erythrocyte morphology by scanning electron microscopy. Studies were carried out in 3 situations: basal state (mean+SEM; Pa02, 5823 mm Hg), after 7 days on oxygen therapy (Pa02, 7 9~4 mm Hg; Pc0.01) and following a 7 day course on allopurinol (300 mg/24 h; Pa02, 58+3 mm Hg). iATP concentrations were similar in the 3 expermental conditions. However, significant differences were observed with respect to the distribution of discocytes, stomatocytes and sphero-stomatocytes. Stomafocytes decreased markedly from a mean base-line number of 23.8% of total red cells to 12.m on oxygen therapy (Pc0.001) and to 14.5% on allopurinol (P<0.001). These data indicate that hypoxemia promotes red cell morphologic alterations that do not depend on iATP levels. Short-term allopurinol administration to COPD patients decreases morphologically abnormal cells by reducing the production of stomatocytes to a level similar to that observed with oxygen therapy. Wlth advancing gestatlon, growth of the placenta stops before the deceleration of fetal growth, and carpllcatlons related to placental Insufficiency becane more c m . It has been postulated that the fetus "outgrows" its placenta. We have carpared the metabolic prcpertles (purlne nucleotide synthesis and their catabolism In response to oxygen and glucose deprivation) of trophoblastlc cells, cultured frcm flrst (1) and third (111) trlmesLer h m n placentae and s h a m by imnunofluorescence (cytokeratln) and hormone production (chorlonlc gonadotropin) to retain their speclallzed trophoblastlc character In primary culture.
SHOULD DIETARY RESTRICTIONS ALWAYS BE PRESCRIBED IN THE TREATMENT OF GOUT

C W G E S IN TROPHOBLASTIC PURINE METABOLISM WITH
Purine synthesis de novo (14-C-fomte incorporation) In I was two orders of magnitude lower than In fetal fibroblasts, but even lower C1/4) in 111. The rate of 14-C-hypoxanthlne phosphorlbosylation was at least 10-fold hlgher than de novo synthesis In both I and 111, and unresponsive to hlgh extracellular PI. ATP level or energy charge (EC) were not Influenced by glucose or oxygen deprivation for 8 hr, but 2-deoxyglucose caused a fa1 I in prelabeled ATP to 1/5 and In EC to 0.42-0.46 (control 0.66-0.71) In 30 min in both I and 111. lnhlbition of oxldatlve phosphorylatlon by rotenone had similar effects than 2-dwxyglucose in I l l , but slgniflcantly more delayed in I.
Ile conclude that h m n trophoblast at t e n Is metabolically less active and less tolerant to energy substrate deprlvatlon than early In gestation.
ARTEFACTS DUE TO RADIATION-INDUCED CELL D W G E IN PULSE-LABELING EXPERIMENTS USING TRITIATED NUCLEIC
124 ACID PRECURSORS. Juha Salonen. Karl 0. Ralvlo, and Laurl Sax&.
Department of Pathology and Chl ldren's Hospital, University of Helsinki: Helslnki, Flnland.
In studies on mhryonlc Induction, unexpected results were obtained when cultured kidney tlssue frcm mouse d r y o s was pulse-labeled wi th 3H-thymidine or-adenine and then subcultivated. A 2-h pulse of 20 pCI led in 2-3 days to mrphologically detectable cell death In the mesenchyme and to Impalred growth. After day 1, the DNA content of untreated control explants increased linearly, whereas no increase occurred In labeled explants until day 4, when a linear growth phase ensued.
On day 8 the DNA content was 50-60% of the controls. Onset of linear growth coincided with the disappearance of label fran the acid-insoluble fractlon of the tissues, suggesting ellrnlnatlon of the initially labeled cells. In tissues treated with high pulses, the adenylate energy charge in the acid-soluble extracts decreased to 0.5.
We postulated that radiation-induced DNA damage activates pol y(ADP-ribose)pol ymerase, which leads to cons~npt ion of NAD and a rapid drop in the ATP-level, eventually result lng in cell death. Dose-dependence experiments supported our hypothesis: label lng of the acid-Insoluble fractlon Increased linearly until a pulse of 10 pCi 3-H-adenine, whereafter the curve leveled off. The crltical point corresponds to ca. 1-5 DPM/ng DNA. The level lng-off was prevented by 3-anlnobenzanlne, an lnhl bl tor of pol y(ADP-ribose) polymerase.
Our findings suggest that subsequent cell growth may be affected by rather low doses of low-energy radiation.
